# Ranolazine in Diastolic Heart Failure

> **NCT01163734** · PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 20 (actual)

## Conditions studied

- Diastolic Heart Failure

## Interventions

- **DRUG:** Ranolazine
- **OTHER:** Saline 0.9% and placebo tablet

## Key facts

- **NCT ID:** NCT01163734
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01163734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01163734, "Ranolazine in Diastolic Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01163734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*